arrow
V

Vânia Luiza Deperon Bonato

Universidade de São Paulo
H指数:29
被引数:2,990

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Photoresponsive Nanocarriers for Potentiating Tuberculosis Therapy

光响应纳米载体用于增强结核病治疗

2026-05-130
OA
Integrated humoral and inflammatory signatures predict outcomes in severe COVID-19: a 14-day longitudinal analysis

整合的体液和炎症特征可预测重症COVID-19的结局:一项14天纵向分析

2026-02-240
OAAI
Hyaluronidase treatment is associated with increased cytokine levels and reduced peritoneal neutrophil accumulation during LPS-induced inflammation

透明质酸酶治疗与脂多糖诱导的炎症期间细胞因子水平升高及腹腔中性粒细胞积聚减少相关

2026-01-010
OAAI
Akkermansia muciniphila restrains type 1 diabetes onset by eliciting cDC2 and Treg cell differentiation in NOD and STZ-induced experimental models

Akkermansia muciniphila通过诱导cDC2和Treg细胞分化,在NOD和STZ诱导的实验模型中抑制1型糖尿病的发病。

2025-07-010
PRE
Biogenic silver nanoparticles produced by Trichoderma reesei inhibit SARS-CoV-2 infection, reduce lung viral load and ameliorate acute pulmonary inflammation
2025-01-010
OAAI
Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection
2024-04-013
PRE
Inulin prebiotic ameliorates type 1 diabetes dictating regulatory T cell homing via CCR4 to pancreatic islets and butyrogenic gut microbiota in murine model
2023-11-086
PRE
Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men
2023-11-012
PRE
Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19
CELLS
IF5.2
2023-07-264
OAAI
Xenogeneic mesenchymal stem cell biocurative improves skin wounds healing in diabetic mice by increasing mast cells and the regenerative profile
2023-03-0112
OAAI
The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19
2023-02-197
OAAI
Cell death induced by NLRP3-palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity
2023-01-030
PRE
Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion
2022-08-2111
OA
Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity
2022-07-1522
OA
Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells
2022-06-0632
OA